Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer
Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO
Biote Reaffirms FY26 Guidance For Revenue Above $190M And Adjusted EBITDA Above $38M
Biote Appoints CFO And Chief Business Officer Bob Peterson As Interim CEO And Director, Effective June 8; Bret Christensen Steps Down As CEO
biote Corp. Q1 2026 Earnings Call Summary
biote Corp. (BTMD) Q1 2026 Earnings Call Transcript
biote Q1 Earnings Call Highlights
Biote Corp (NASDAQ:BTMD) Q1 2026: Revenue Miss Despite EPS Beat
Biote Reports First Quarter 2026 Financial Results
Biote Q1 2026 Earnings Call: Complete Transcript
Biote Q1 EPS $0.06 Beats $0.03 Estimate, Sales $44.935M Miss $46.023M Estimate
How The biote (BTMD) Narrative Is Shifting As Targets Tighten And Guidance Holds
Biote Schedules First Quarter 2026 Financial Results Release and Conference Call
Truist Securities Maintains Buy on Biote, Lowers Price Target to $4
How The Investment Story For Biote (BTMD) Is Shifting With Reset Expectations And 2026 Guidance
B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $2
TD Cowen Maintains Buy on Biote, Lowers Price Target to $2.5
Biote Corp (BTMD) Q4 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges
biote Corp. Q4 2025 Earnings Call Summary
biote Corp. (BTMD) Q4 2025 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.